In addition, CXCL12 inhibits DPP4 and accelerates EMT and metastasis in breast cancer,41 and the inhibition of ERBB3 signaling suppresses EMT of hepatocellular carcinoma.42 Here, ERBB3 is linked to breast carcinoma.